• Search
  • Advanced Search

Original Article

November 30, 2025


Impact of Cryoprobe Density on Hemigland Ablation Prostate-Specific Antigen Outcomes
Ashley Monaco, Parth Joshi, Sofia Di Scipio, et al.
J Urol Oncol. 2025;23(3):211-218.

Purpose: Prostate-specific antigen (PSA) value interpretation following primary focal cryotherapy (PFC) for prostate cancer remains a challenge. The purpose of this study is to determine significance of cryoprobe density (CPD),...

Original Article

November 30, 2025


Prognosis of Prostate Cancer With Mucinous Components: A Propensity Score-Matched Study
Jin Hyeok Choi, Hyunho Han, Jongsoo Lee, et al.
J Urol Oncol. 2025;23(3):219-226.

Purpose: Acinar adenocarcinoma with mucinous components is a rare histologic variant of prostate cancer (PC) that was previously reported to exhibit more aggressive behavior than typical PC. However, recent studies...

Original Article

November 30, 2025


Targeted Cascade Genetic Testing in Korean Prostate Cancer Probands: High Detection Rate of Heritable Germline Variants in First-Degree Relatives From a Retrospective Cohort
Sang Hun Song, Jungwon Park, Younsoo Chung, et al.
J Urol Oncol. 2025;23(3):227-235.

Purpose: This study aimed to assess the rate of germline variant detection following targeted cascade genetic testing among family members of prostate cancer (PCa) probands. Materials and Methods: Records of PCa...

Original Article

November 30, 2025


Treatment Patterns and Survival Outcomes in Korean Patients With Metastatic Hormone-Sensitive Prostate Cancer in a Real-World Setting
Sung-Hee Oh, Eunjung Choo, Jae Young Joung, et al.
J Urol Oncol. 2025;23(3):236-246.

Purpose: With the emergence of next-generation therapies, real-world evaluation of current treatment strategies for metastatic hormone-sensitive prostate cancer (mHSPC) is essential. This study aimed to investigate the clinical characteristics, primary...

Original Article

November 30, 2025


Rectal Spacer Gel Displacement of the Rectum During Prostate Cryoablation: A Case Series
Jerad Harris, Robert Will, Eric Robinson, et al.
J Urol Oncol. 2025;23(3):247-252.

Purpose: To describe a novel case series using rectal spacer gel to displace and protect the rectum during prostate cancer cryoablation. Materials and Methods: Fifty men with clinically localized grade group...

Original Article

November 30, 2025


Effectiveness of Guardix-SG in Preventing Postoperative Bowel Complications After Radical Cystectomy: A Single-Arm Prospective Observational Study
Jiwoong Yu, Wan Song, Minyong Kang, et al.
J Urol Oncol. 2025;23(3):253-259.

Purpose: This study aimed to evaluate the effectiveness of intraoperative Guardix-SG application in reducing postoperative ileus (POI) and preventing adhesive small bowel obstruction (SBO) following radical cystectomy (RC) for bladder...

Original Article

November 30, 2025


Multimodal Prehabilitation for Cystectomy Using the Comprehensive Geriatric Assessment: Design and Implementation
Anthony J. Teixeira, Emily H. Roebuck, Lila G. McGrath, et al.
J Urol Oncol. 2025;23(3):260-267.

Purpose: This study describes the design and implementation of a multimodal prehabilitation program for patients undergoing radical cystectomy, utilizing the comprehensive geriatric assessment (CGA) to identify and address preoperative impairments....

Original Article

November 30, 2025


Prognostic Value of a Trifecta for Predicting Survival Outcomes After Radical Cystectomy: A Large-Scale Multicenter Study
Jong Ho Park, Sangchul Lee, Seung-Hwan Jeong, et al.
J Urol Oncol. 2025;23(3):268-279.

Purpose: This study aimed to evaluate the prognostic value of a trifecta, defined as negative soft tissue surgical margin (STSM), removal of ≥16 lymph nodes, and absence of major complications...

Original Article

November 30, 2025


Changes in Radical Cystectomy Discharge Disposition During the COVID-19 Pandemic: Data in Support of an Efficient Care Pathway
Aniket Asees, Kathryn A. Marchetti, Violet Clarkberg, et al.
J Urol Oncol. 2025;23(3):280-288.

Purpose: Radical cystectomy is a high-risk procedure commonly followed by discharge to home with home care or long-term care facilities. The coronavirus disease 2019 (COVID-19) pandemic disrupted healthcare delivery and...

Original Article

November 30, 2025


Next-Generation Sequencing Reveals Differentially Expressed Genes and Pathways in Urethral Cancer: Exploring A Poorly Understood Malignancy
Nickolas Kinachtchouk, Samantha Freeman, Rachael Gotlieb, et al.
J Urol Oncol. 2025;23(3):289-298.

Purpose: Primary urethral cancer (PUC) is an uncommon malignancy with scarce diagnostic and treatment options, resulting in a limited understanding of its genetic foundation. This exploratory study compares gene expression...
Current Issue
Volume 23(3); Nov 2025
Health Equity Research Outcomes and Improvement Consortium Prostate Cancer Health Precision Africa1K: Closing the Health Equity Gap Through Rural Community Inclusion
Vanessa M. Hayes, Sean M. Patrick, Joyce Shirinde, et al.
J Urol Oncol. 2024;22(2):144-149.

Invited Review

Jul 31, 2024

Prostate Cancer
Prostate-Specific Antigen-Based Prostate Cancer Screening: One for All or Individualized for Each Race? – A Narrative Review
Chang Wook Jeong
J Urol Oncol. 2024;22(1):4-10.

Invited Review

Mar 31, 2024

Prostate Cancer
Trimodal Therapy in the Treatment of Muscle-Invasive Bladder Cancer
Yongsoo Jo, Hyeong Dong Yuk
J Urol Oncol. 2024;22(3):256-267.

Invited Review

Nov 30, 2024

Bladder Cancer
Global Renal Cell Carcinoma Research Trends Over 30 Years: A PRISMA-Compliant Bibliometric Analysis
Jung Hoon Kim, Ji Woong Hwang
J Urol Oncol. 2024;22(1):42-51.

Original Article

Mar 31, 2024

Kidney Cancer
Delivering on the Promise of Precision Oncology in Prostate Cancer: Prediagnostic Strategies, Postdiagnostic Applications, and Future Directions. A Narrative Review
Gabriela M. Diaz, Peter S. Palencia, Michael S. Leapman
J Urol Oncol. 2025;23(1):4-13.

Invited Review

Mar 31, 2025

Prostate Cancer
Multidisciplinary Team Approach in Prostate-Specific Membrane Antigen Theranostics for Prostate Cancer: A Narrative Review
Minseok Suh, Gi Jeong Cheon
J Urol Oncol. 2024;22(1):11-20.

Invited Review

Mar 31, 2024

Prostate Cancer
Robot-Assisted Radical Nephrectomy With Inferior Vena Cava Thrombectomy: A Narrative Review With Step-by-Step Procedures
Seokhwan Bang, Sung-Hoo Hong
J Urol Oncol. 2024;22(2):105-114.

Invited Review

Jul 31, 2024

Renal Cell Carcinoma
Pathologic Diagnosis of Renal Cell Carcinoma in the Era of the 2022 World Health Organization Classification: Key Points for Clinicians
Bokyung Ahn, Jinahn Jeong, Yong Il Lee, et al.
J Urol Oncol. 2024;22(2):115-127.

Invited Review

Jul 31, 2024

Renal Cell Carcinoma
The Emerging Treatment of BCG (Bacillus Calmette-Guérin)-Unresponsive Non–Muscle-Invasive Bladder Cancer
Jong Ho Park, Jong Jin Oh
J Urol Oncol. 2024;22(3):246-255.

Invited Review

Nov 30, 2024

Bladder Cancer
Artificial Intelligence: The Latest Advances in the Diagnosis of Bladder Cancer
Satyendra Singh, Ram Mohan Shukla
J Urol Oncol. 2024;22(3):268-280.

Review Article

Nov 30, 2024

Bladder Cancer
Nephron-Sparing Surgery for Upper Urinary Tract Urothelial Carcinoma
Sung Han Kim, Ilma S. Savul, Seth P. Lerner
J Urol Oncol. 2024;22(1):68-77.

Invited Review

Mar 31, 2024

Bladder Cancer
Prognostic Factors and Cancer-Specific Survival of Surgically Managed Renal Cell Carcinoma With Venous Thrombus: A 30-Year Experience at a Tertiary Referral Center
Hyun Young Lee, Yunjoong Kim, Bumjin Lim, et al.
J Urol Oncol. 2024;22(1):52-58.

Original Article

Mar 31, 2024

Kidney Cancer
Clinical Characteristics and Outcomes of TFE3-Rearranged/TFEB-Altered Renal Cell Carcinoma with Systemic Therapies, Including Tyrosine Kinase Inhibitors or Immune Checkpoint Inhibitors: An Observational Study
Joohyun Hong, Ghee Young Kwon, Minyong Kang, et al.
J Urol Oncol. 2024;22(1):59-67.

Original Article

Mar 31, 2024

Kidney Cancer
Targeted Therapy Following Metastasectomy for Metastatic Renal Cell Carcinoma: A Systematic Review and Meta-analysis
Hui Mo Gu, Seung Il Jung, Dongdeuk Kwon, et al.
J Urol Oncol. 2024;22(1):34-41.

Systemic Review and Meta-analysis

Mar 31, 2024

Kidney Cancer
The Role of Fibroblast Growth Factor Receptors Inhibitors in Bladder Cancer
Ho Kyung Seo, Eui Hyun Jung, Sora Yang, et al.
J Urol Oncol. 2024;22(2):166-177.

Invited Review

Jul 31, 2024

Bladder Cancer
Effects of Neoadjuvant Chemotherapy on Rates of Depression in Muscle Invasive Bladder Cancer
Matthew DeSanto, Frank H. Annie, Stacie Deslich, et al.
J Urol Oncol. 2024;22(2):178-182.

Original Article

Jul 31, 2024

Bladder Cancer
Early Experience of the Single-Port Robotic Transvesical Radical Prostatectomy: Case Series
Jae Hoon Chung, Hwanik Kim, Woo Jin Bang, et al.
J Urol Oncol. 2024;22(3):188-195.

Original Article

Nov 30, 2024

Prostate Cancer
Poorer Outcomes in Bladder Cancer Patients With Diabetes: A Systematic Review and Meta-analysis Addressing Over 226,472 Bladder Cancer Patients
Stefani Frost, Parisa Ziarati, Ryan Moen, et al.
J Urol Oncol. 2024;22(1):78-94.

Systemic Review and Meta-analysis

Mar 31, 2024

Bladder Cancer
Enzalutamide Maintenance Following Docetaxel in Metastatic Castration-Naive Prostate Cancer: A Pilot Feasibility Study
Sung Hee Lim, Sung Wook Cho, Jae Hoon Chung, et al.
J Urol Oncol. 2024;22(1):29-33.

Original Article

Mar 31, 2024

Prostate Cancer
High-Grade Late Urinary Toxicity Following Salvage Radiotherapy After Radical Prostatectomy: A Retrospective Cohort Study
Seung-Kwon Choi, Myong Kim, Sang Mi Lee, et al.
J Urol Oncol. 2024;22(1):21-28.

Original Article

Mar 31, 2024

Prostate Cancer
A Narrative Review on Systemic Therapy for Renal Cell Carcinoma in the Perioperative Setting
Isamu Tachibana, Qian Qin, Jacob Taylor, et al.
J Urol Oncol. 2024;22(2):100-104.

Invited Review

Jul 31, 2024

Renal Cell Carcinoma
Diagnostic Accuracy of Contrast-Enhanced Ultrasonography for the Assessment of Small Renal Mass: A Prospective Study
Jae-Wook Chung, Seo Young Park, Seunghee Woo, et al.
J Urol Oncol. 2024;22(2):128-135.

Original Article

Jul 31, 2024

Renal Cell Carcinoma
Comparison of Outcomes Between Radical Nephrectomy and Partial Nephrectomy in Clinical T2 Renal Cell Carcinoma: A Retrospective Korean Renal Cell Carcinoma Cohort Study
Younsoo Chung, Seok-Soo Byun, Sung Kyu Hong, et al.
J Urol Oncol. 2024;22(2):136-143.

Original Article

Jul 31, 2024

Renal Cell Carcinoma
The Integral Role and Clinical Significance of Metabolic Profiling in Prostate Cancer: A Narrative Review
Valentin Nikolaevich Pavlov, Marat Fayazovich Urmantsev, Marat Radikovich Bakeev, et al.
J Urol Oncol. 2024;22(2):150-156.

Review Article

Jul 31, 2024

Prostate Cancer
Changes in Treatment After Gallium-68 Prostate-Specific Membrane Antigen-11 Positron Emission Tomography/Computed Tomography in Patients With Prostate Cancer: A Retrospective Case Series Study
Si Hyun Kim, Chang Wook Jeong, Minh-Tung Do, et al.
J Urol Oncol. 2024;22(2):157-165.

Original Article

Jul 31, 2024

Prostate Cancer
Simultaneous Prostate Target Biopsy Integrated With Radical Prostatectomy: A Pilot Study Omitting Preoperative Systematic Biopsy
Tae Young Park, Jae Young Hwang, Seong Woo Yun, et al.
J Urol Oncol. 2024;22(3):196-200.

Original Article

Nov 30, 2024

Prostate Cancer
A Machine Learning Model for Prostate Cancer Prediction in Korean Men
Sukjung Choi, Beomgi So, Shane Oh, et al.
J Urol Oncol. 2024;22(3):201-210.

Original Article

Nov 30, 2024

Prostate Cancer
Assessing Patient Risk, Benefit, and Outcomes in Drug Development: A Decade of Abiraterone Clinical Trials
Matthew Rashid, Eli Oldham, Griffin K. Hughes, et al.
J Urol Oncol. 2024;22(3):211-223.

Original Article

Nov 30, 2024

Prostate Cancer
The Current Role of Metastasis-Directed Therapy for Oligometastatic Renal Cell Carcinoma
Hyung Joon Kim
J Urol Oncol. 2024;22(3):224-227.

Brief Report

Nov 30, 2024

Kidney Cancer
Exploring the Evolving Role of Metastasectomy in Advanced Renal Cell Carcinoma
Jongkyou Kwon, Sungun Bang, Kang Su Cho
J Urol Oncol. 2024;22(3):228-236.

Invited Review

Nov 30, 2024

Kidney Cancer

Journal of
Urologic Oncology

Print ISSN: 2951-603X
Online ISSN: 2982-7043

Editorial Office
Department of Urology, Seoul National University Hospital, Seoul National University College of Medicine,
101 Daehak-ro, Jongno-gu, Seoul 03080, Korea
TEL: +82-2-2072-0817,   FAX: +82-2-742-4665   Email: journal@e-juo.org
Korean Urological Oncology Society
50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea
Tel: +82-2-704-8574, E-mail: leeseh@yuhs.ac

Copyright © The Korean Urological Oncology Society.

Developed in M2PI